The forecasting model projects that without major intervention, 1.8 billion people will have MASLD by 2050, and a ...
Metabolic liver disease (MASLD) could affect 1.8 billion people by 2050, driven by rising obesity and high blood sugar, a ...
A silent liver condition is rising worldwide, with subtle symptoms many people overlook until it’s too late.
A report in The Lancet shows that fatty liver disease cases have surged all over the world since 1990. It now affects over a ...
Fatty liver disease happens when too much fat builds up in the liver. Metabolic dysfunction-associated steatohepatitis (MASH) is a severe type of fatty liver disease where fat buildup causes liver ...
GLP-1 drugs have direct beneficial effects on the liver, independent of their benefits for obesity, researchers studying the ...
If someone asked about your heart health, you could probably list off your cholesterol numbers or even your latest A1C ...
Irish Examiner on MSN
Liver disease to affect 1.8 billion people worldwide by 2050, study suggests
Projected increase in cases of metabolic liver disease attributed to rising obesity and blood sugar levels along with ...
Researchers have found that semaglutide, the active ingredient in popular weight loss drugs that mimic the gut hormone GLP-1, ...
Fatty liver disease (also called steatotic liver disease) happens when too much fat builds up in your liver. It can be caused by high alcohol use or metabolic syndrome (a group of conditions like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results